Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jul;22(7):1030–1041. doi: 10.1016/S1473-3099(21)00744-1

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Value of vaccination against gonorrhoea under three targeting strategies among men who have sex with men in England over 10 years

(A) Heatmaps of median value per dose administered of vaccines providing 1–100% protection against infection for 1–20 years, with contour lines showing values of £50, £100, £150, and £200. (B) Impact of duration of protection on the median value per dose administered of vaccines with a range of efficacies. (C) Impact of efficacy on the median value per dose administered of vaccines with a range of durations of protection. Columns of panels correspond to the three targeting strategies assessed (VoD, VaR, and VoA). The lines plotted in panels B and C are transects through the heatmaps in panel A, with value represented on the vertical axis rather than by colour. Vaccine uptake is 33·0% (95% CI 32·7–33·3). VoD=vaccination on diagnosis. VaR=vaccination according to risk. VoA=vaccination on attendance.